Transgender breast pathology.
Baker, GM, and YJ Heng. 2021. “Transgender Breast Pathology.”. PathologyOutlines.Com. 2021.
Search
Search results
89 results found
Immunohistochemistry scoring of breast tumor tissue microarrays: a comparison study across three software applications.
Baker, GM, VC Bret-Mounet, Wang, Veta, Zheng, LC Collins, AH Eliassen, RM Tamimi, and YJ Heng. 2022. “Immunohistochemistry Scoring of Breast Tumor Tissue Microarrays: A Comparison Study across Three Software Applications.”. J Path Inform 13: 100118.
PARP-inhibition reprograms macrophages towards an anti-tumor phenotype
Wang, L., D. Wang, Sonzogni, Ke, Q. Wang, Thavamani, Batalini, et al. 2022. “PARP-Inhibition Reprograms Macrophages towards an Anti-Tumor Phenotype”. Cell Rep 41 (2): 111462.
Reliability of CD44, CD24, and ALDH1A1 immunohistochemical staining: pathologist assessment compared to quantitative image analysis
Yaghjyan, YJ Heng, GM Baker, VC Bret-Mounet, Murphy, Mahoney, Mu, BA Rosner, and RM Tamimi. 2022. “Reliability of CD44, CD24, and ALDH1A1 Immunohistochemical Staining: Pathologist Assessment Compared to Quantitative Image Analysis”. Front Med 9: 1040061.
Reliability of breast stromal markers immunofluorescent staining: pathologist assessment compared to quantitative image analysis
Yaghjyan, Lusine, Yujing J. Heng, Yaileen D Guzman-Arocho, Graham Colditz, Brian R Sardella, Ann Fu, K Patel, Bernard A Rosner, Maisey Ratcliff, and Rulla M Tamimi. Submitted. “Reliability of Breast Stromal Markers Immunofluorescent Staining: Pathologist Assessment Compared to Quantitative Image Analysis”. Submitted, Submitted.
Associations of alcohol consumption with expression of CD44, CD24, and ALDH1A1 stem cell markers in benign breast biopsy samples
Ratcliffe, Maisey, Lusine Yaghjyan, Yujing J Heng, Gabrielle M Baker, Bernard A Rosner, and Rulla M Tamimi. 2025. “Associations of Alcohol Consumption With Expression of CD44, CD24, and ALDH1A1 Stem Cell Markers in Benign Breast Biopsy Samples”. Cancer Causes Control 36: 1489-97.
Genomic and Transcriptomic Landscape and Determinants of Response of BRCA-related Breast Cancers Treated with Neoadjuvant Chemotherapy (TBCRC 031)
Batalini, Felipe, Nadine Tung, Tae-Hee Clara Kim, Xanthi-Lida Katopodi, Nikolas Kalavros, Antuan Tran, Dimitra Karagkouni, et al. Submitted. “Genomic and Transcriptomic Landscape and Determinants of Response of BRCA-Related Breast Cancers Treated With Neoadjuvant Chemotherapy (TBCRC 031)”. Submitted, Submitted.
MicroRNA spatial profiling for assessing drug efficacy in BRCA1-related triple-negative breast tumors
Mohd, Omar N, Lin Wang, Brian R Sardella, David Jou, Gerburg M Wulf, Frank J Slack, Yujing J Heng, and Patrick S Doyle. 2026. “MicroRNA Spatial Profiling for Assessing Drug Efficacy in BRCA1-Related Triple-Negative Breast Tumors”. BioRxiv, 2026.01.12.698824.
Masculinizing Testosterone Therapy Reduces the Incidence of PIK3CA-Mutant/ER+ Breast Cancer but Not BRCA1-Associated Triple-Negative Breast Cancer
Wang, Lin, Brian R Sardella, Abhishek Thavamani, Erica S Massicott, Vanessa C Bret-Mounet, Gabrielle M Baker, Yaileen D Guzman-Arocho, et al. 2025. “Masculinizing Testosterone Therapy Reduces the Incidence of PIK3CA-Mutant/ER+ Breast Cancer But Not BRCA1-Associated Triple-Negative Breast Cancer”. MedRxiv, 2025.09.15.25335324.
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53.
Lee, JD, B Menasche, M Mavrikaki, M Uyemura, SM Hong, N Kozlova, J Wei, et al. 2023. “Differences in Syncytia Formation by SARS-CoV-2 Variants Modify Host Chromatin Accessibility and Cellular Senescence via TP53.”. Cell Rep 42: 113478.